346 related articles for article (PubMed ID: 17938126)
21. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.
Stone GW; Ellis SG; Cox DA; Hermiller J; O'Shaughnessy C; Mann JT; Turco M; Caputo R; Bergin P; Greenberg J; Popma JJ; Russell ME;
N Engl J Med; 2004 Jan; 350(3):221-31. PubMed ID: 14724301
[TBL] [Abstract][Full Text] [Related]
22. [Drug-eluting stents for diabetic patients. A critical appraisal of the currently available data from randomized trials].
Silber S; Herdeg C
Herz; 2008 Apr; 33(3):196-205. PubMed ID: 18568314
[TBL] [Abstract][Full Text] [Related]
23. Long-term outcome of adjunctive celecoxib treatment after paclitaxel-eluting stent implantation for the complex coronary lesions: two-year clinical follow-up of COREA-TAXUS trial.
Chung JW; Yang HM; Park KW; Lee HY; Park JS; Kang HJ; Cho YS; Youn TJ; Koo BK; Chae IH; Choi DJ; Oh BH; Park YB; Kim HS
Circ Cardiovasc Interv; 2010 Jun; 3(3):243-8. PubMed ID: 20484099
[TBL] [Abstract][Full Text] [Related]
24. What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis.
Bavry AA; Kumbhani DJ; Helton TJ; Bhatt DL
J Am Coll Cardiol; 2005 Mar; 45(6):941-6. PubMed ID: 15766833
[TBL] [Abstract][Full Text] [Related]
25. Comparison of short- and mid-term outcomes between CYPHER and TAXUS stents in patients with complex lesions of the coronary arteries.
Chen JL; Gao RL; Yang YJ; Qiao SB; Qin XW; Yao M; Liu HB; Xu B; Wu YJ; Yuan JQ; Chen J; Dai J; You SJ; Ma WH
Chin Med J (Engl); 2006 Jan; 119(1):21-5. PubMed ID: 16454977
[TBL] [Abstract][Full Text] [Related]
26. Impact of moderate renal insufficiency on restenosis and adverse clinical events after paclitaxel-eluting and bare metal stent implantation: results from the TAXUS-IV Trial.
Halkin A; Mehran R; Casey CW; Gordon P; Matthews R; Wilson BH; Leon MB; Russell ME; Ellis SG; Stone GW
Am Heart J; 2005 Dec; 150(6):1163-70. PubMed ID: 16338253
[TBL] [Abstract][Full Text] [Related]
27. Polymer-based paclitaxel-eluting stents in percutaneous coronary intervention: a review of the TAXUS trials.
Halkin A; Stone GW
J Interv Cardiol; 2004 Oct; 17(5):271-82. PubMed ID: 15491330
[TBL] [Abstract][Full Text] [Related]
28. Incidence of thrombosis after implantation of drug-eluting stents in patients with coronary artery disease.
Chen JL; Yang YJ; Gao LJ; Huang JH; Qin XW; Qiao SB; Xu B; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Li JJ; Gao RL
Chin Med J (Engl); 2008 Nov; 121(21):2144-7. PubMed ID: 19080174
[TBL] [Abstract][Full Text] [Related]
29. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions.
Fan L; Chen LL; Lin CG; Peng YF; Zheng XC; Luo YK; Zhang FL; Chen JH; Yan XP; Huang ZR
Chin Med J (Engl); 2008 Aug; 121(16):1518-23. PubMed ID: 18982862
[TBL] [Abstract][Full Text] [Related]
30. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.
Mehilli J; Kastrati A; Byrne RA; Bruskina O; Iijima R; Schulz S; Pache J; Seyfarth M; Massberg S; Laugwitz KL; Dirschinger J; Schömig A;
J Am Coll Cardiol; 2009 May; 53(19):1760-8. PubMed ID: 19422982
[TBL] [Abstract][Full Text] [Related]
31. Preclinical and early clinical experience with a biodegradable polymer-based, rapamycin-eluting, Indian drug-eluting coronary stent: the BIO-RAPID study.
Bhargava B; Karthikeyan G; Shankar PB; Seth S; Singh S; Pr U; Lal AV; Mohanty M
Indian Heart J; 2008; 60(3):228-32. PubMed ID: 19240312
[TBL] [Abstract][Full Text] [Related]
32. [Treatment of lesions with a high risk of stenosis. Comparative study in 300 patients of rapamycin- and Paclitaxel-eluting polymer-based stents, and bare metal stents].
de la Torre Hernández JM; Sainz Laso F; Ruisánchez C; Zueco J; Figueroa A; Colman T
Rev Esp Cardiol; 2005 Mar; 58(3):262-9. PubMed ID: 15766448
[TBL] [Abstract][Full Text] [Related]
33. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.
Whan Lee C; Kim SH; Suh J; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
Catheter Cardiovasc Interv; 2008 Apr; 71(5):594-8. PubMed ID: 18311841
[TBL] [Abstract][Full Text] [Related]
34. Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
Alfonso F; Pérez-Vizcayno MJ; Hernández R; Bethencourt A; Martí V; López-Mínguez JR; Angel J; Iñiguez A; Morís C; Cequier A; Sabaté M; Escaned J; Jiménez-Quevedo P; Bañuelos C; Suárez A; Macaya C;
J Am Coll Cardiol; 2008 Nov; 52(20):1621-7. PubMed ID: 18992651
[TBL] [Abstract][Full Text] [Related]
35. Long-term outcomes of drug-eluting versus bare-metal stent implantation in patients with chronic total coronary artery occlusions.
Han YL; Zhang J; Li Y; Wang SL; Jing QM; Yi XH; Ma YY; Luan B; Wang G; Wang B
Chin Med J (Engl); 2009 Mar; 122(6):643-7. PubMed ID: 19323927
[TBL] [Abstract][Full Text] [Related]
36. A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stents.
Byrne RA; Mehilli J; Iijima R; Schulz S; Pache J; Seyfarth M; Schömig A; Kastrati A
Eur Heart J; 2009 Apr; 30(8):923-31. PubMed ID: 19240066
[TBL] [Abstract][Full Text] [Related]
37. Clinical outcomes following drug-eluting versus bare metal stent implantation for lesion subsets excluded from pivotal clinical trials: findings from the GHOST Study (Guthrie Health System Off-Label StenT Study).
Harjai KJ; Orshaw P; Shenoy C; Acharji S; Sporn D; Aboufares A; Stapleton D
J Interv Cardiol; 2008 Aug; 21(4):315-24. PubMed ID: 18754967
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the incidence of late stent thrombosis after implantation of different drug-eluting stents in the real world coronary heart disease patients: three-year follow-up results.
Chen JL; Gao LJ; Yang YJ; Li JJ; Qiao SB; Xu B; Huang JH; Yao M; Qin XW; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Gao RL
Chin Med J (Engl); 2010 Apr; 123(7):778-81. PubMed ID: 20497663
[TBL] [Abstract][Full Text] [Related]
39. Long-term outcomes in treating left main trifurcation coronary artery disease with the Paclitaxel-eluting stent.
Shammas NW; Dippel EJ; Avila A; Gehbauer L; Farland L; Brosius S; Jerin M; Winter M; Stoakes P; Byrd J; Majetic L; Shammas G; Sharis P; Robken J
J Invasive Cardiol; 2007 Feb; 19(2):77-82. PubMed ID: 17268042
[TBL] [Abstract][Full Text] [Related]
40. Clinical outcomes after multilesion percutaneous coronary intervention: comparison between exclusive and selective use of drug-eluting stents.
Bertrand OF; Faurie B; Larose E; Nguyen CM; Gleeton O; Déry JP; Noël B; Proulx G; Roy L; Costerousse O; De Larochellière R; Rodés-Cabau J
J Invasive Cardiol; 2008 Mar; 20(3):99-104. PubMed ID: 18316823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
